1. Comparison of the Antiviral Activity of the Microbicide Candidate Griffithsin and Its Tandemers Derivatives against Different Modes of HIV-1 Transmission. Alexandre, K., K. Malatji, and T. Mulaudzi. Virology, 2020. 544: p. 12-20. PMID[32174510].
[PubMed]. HIV_04_2020.
2. Design, Synthesis, Molecular Modeling Study and Biological Evaluation of New N '-Arylidene-pyrido[2,3-d]pyrimidine-5-carbohydrazide Derivatives as anti-HIV-1 Agents. Ebrahimzadeh, E., S.A. Tabatabai, R. Vahabpour, Z. Hajimandi, and A. Zarghi. Iranian Journal of Pharmaceutical Research, 2019. 18: p. 237-248. ISI[000519539900018].
[WOS]. HIV_04_2020.
3. Optimization of the Benzyl Moiety in 2-Pyridone Aminals as HIV Integrase Strand Transfer Inhibitors (INSTIS).Ferguson, R., T. Yu, Y.L. Zhang, T. Graham, W.S. Liu, S. Waddell, A. Stamford, A. Walji, I. Raheem, J. Wai, P. Coleman, A. Verras, J. Sanders, M. Xu, J. Grobler, and J. Schreier. Abstracts of Papers of the American Chemical Society, 2019. 258. ISI[000525055501545].
[WOS]. HIV_04_2020.
4. Design, Synthesis, in Vitro and in Silico Studies of Novel 4-Oxoquinoline ribonucleoside Derivatives as HIV-1 Reverse Transcriptase Inhibitors. Forezi, L.D.M., M.M.J. Ribeiro, A. Marttorelli, J.L. Abrantes, C.R. Rodrigues, H.C. Castro, T.M.L. Souza, F.C.S. Boechat, A.M.T. de Souza, and M. de Souza. European Journal of Medicinal Chemistry, 2020. 194. PMID[32244098].
[PubMed]. HIV_04_2020.
5. A Comparison of Different Immune Activation Strategies to Reverse HIV-1 Latency. Garliss, C.C., A.K. Kwaa, and J.N. Blankson. Open Forum Infectious Diseases, 2020. 7(4): ofaa082. PMID[32284948]. PMCID[PMC7139987].
[PubMed]. HIV_04_2020.
6. (Thia)calixarenephosphonic acids as Potent Inhibitors of the Nucleic acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity.Humbert, N., L. Kovalenko, F. Saladini, A. Giannini, M. Pires, T. Botzanowski, S. Cherenok, C. Boudier, K.K. Sharma, E. Real, O.A. Zaporozhets, S. Cianferani, C. Seguin-Devaux, F. Poggialini, M. Botta, M. Zazzi, V.I. Kalchenko, M. Mori, and Y. Mely. ACS Infectious Diseases, 2020. 6(4): p. 687-702. PMID[32045204].
[PubMed]. HIV_04_2020.
7.The Comparative Analysis of Antiviral Activity of Native and Modified Fucoidans from Brown Algae Fucus evanescens in Vitro and in Vivo.Krylova, N.V., S.P. Ermakova, V.F. Lavrov, I.A. Leneva, G.G. Kompanets, O.V. Iunikhina, M.N. Nosik, L.K. Ebralidze, I.N. Falynskova, A.S. Silchenko, and T.S. Zaporozhets. Marine Drugs, 2020. 18(4). PMID[32331442].
[PubMed]. HIV_04_2020.
8. Selective Class I HDAC Inhibitors Based on Aryl ketone zinc Binding Induce HIV-1 Protein for Clearance.Liu, J., J. Kelly, W.S. Yu, D. Clausen, Y.N. Yu, H.J. Kim, J. Duffy, C. Chang, R. Myers, D. Klein, J. Fells, K. Holloway, J. Wu, G.X. Wu, B. Howell, R. Barnard, and J. Kozlowski. Abstracts of Papers of the American Chemical Society, 2019. 258. ISI[000525061502050].
[WOS]. HIV_04_2020.
9. Bioactive Prenylated coumarins as Potential Anti-inflammatory and anti-HIV Agents from Clausena lenis. Liu, Y.P., G. Yan, Y.T. Xie, T.C. Lin, W. Zhang, J. Li, Y.J. Wu, J.Y. Zhou, and Y.H. Fu. Bioorganic Chemistry, 2020. 97: 103699. PMID[32146173].
[PubMed]. HIV_04_2020.
10. Mo(VI) Complex Catalysed Synthesis of Sulfones and Their Modification for anti-HIV Activities. Madduluri, V.K., N. Baig, S. Chander, S. Murugesan, and A.K. Sah. Catalysis Communications, 2020. 137: 105931. ISI[000519664200004].
[WOS]. HIV_04_2020.
11. Long-acting Rilpivirine (RPV) Preexposure Prophylaxis Does Not Inhibit Vaginal Transmission of RPV-Resistant HIV-1 or Select for High-frequency Drug Resistance in Humanized Mice.Melody, K., C.N. Roy, C. Kline, M.L. Cottrell, D. Evans, K. Shutt, P.S. Pennings, B.F. Keele, M. Bility, A.D.M. Kashuba, and Z. Ambrose. Journal of Virology, 2020. 94(8): e01912-19. PMID[31969438]. PMCID[PMC7108851].
[PubMed]. HIV_04_2020.
12. Trim34 Restricts HIV-1 and SIV Capsids in a Trim5alpha-dependent Manner. Ohainle, M., K. Kim, S. Komurlu Keceli, A. Felton, E. Campbell, J. Luban, and M. Emerman. Plos Pathogens, 2020. 16(4): e1008507. PMID[32282853]. PMCID[PMC7179944].
[PubMed]. HIV_04_2020.
13. Thiostrepton Reactivates Latent HIV-1 through the p-TEFb and NF-kappaB Pathways Mediated by Heat Shock Response. Peng, W., Z. Hong, X. Chen, H. Gao, Z. Dai, J. Zhao, W. Liu, D. Li, and K. Deng. Antimicrobial Agents and Chemotherapy, 2020. 64(5): e02328-19. PMID[32094131]. PMCID[PMC7179580].
[PubMed]. HIV_04_2020.
14. Synthesis, Spectroscopic Properties, Quantum Chemical Calculations, and Biological Activities of 2-{[5-(2-Fluorophenyl)-4-(4-methylphenyl)-4H-1,2,4-Triazol-3-yl]sulfanyl }-1-[3-methyl-3-(2,4,6-trimethylphenyl)-cyclobutyl]ethan-1-one. Sarac, K. Russian Journal of Organic Chemistry, 2020. 56(1): p. 119-128. ISI[000520467600019].
[WOS]. HIV_04_2020.
15. Identification of Novel Compounds against Tat-tediated Human Immunodeficiency Virus-1 Transcription by High-throughput Functional Screening Assay. Shin, Y., H.G. Kim, C.M. Park, M.S. Choi, D.E. Kim, B.S. Choi, K. Kim, and C.H. Yoon. Biochemical and Biophysical Research Communications, 2020. 523(2): p. 368-374. PMID[31866007].
[PubMed]. HIV_04_2020.
16. Plant-based Production of Highly Potent anti-HIV Antibodies with Engineered Posttranslational Modifications. Singh, A.A., O. Pooe, L. Kwezi, T. Lotter-Stark, S.H. Stoychev, K. Alexandra, I. Gerber, J.N. Bhiman, J. Vorster, M. Pauly, L. Zeitlin, K. Whaley, L. Mach, H. Steinkellner, L. Morris, T.L. Tsekoa, and R. Chikwamba. Scientific Reports, 2020. 10(6201): 9pp. PMID[32277089]. PMCID[PMC7148297].
[PubMed]. HIV_04_2020.
17. In Vitro Antimicrobial Activity of Essential Oil Extracted from Leaves of Leoheo domatiophorus Chaowasku, D.T. Ngo and H.T. Le in Vietnam. Trong Le, N., D. Viet Ho, T. Quoc Doan, A. Tuan Le, A. Raal, D. Usai, S. Madeddu, M. Marchetti, M. Usai, P. Rappelli, N. Diaz, S. Zanetti, H.T. Nguyen, P. Cappuccinelli, and M.G. Donadu. Plants, 2020. 9(4): E453. PMID[32260297].
[PubMed]. HIV_04_2020.
18. Sustained-release Griffithsin Nanoparticle-fiber Composites against HIV-1 and HSV-2 Infections. Tyo, K.M., A.B. Lasnik, L.Y. Zhang, M. Mahmoud, A.B. Jenson, J.L. Fuqua, K.E. Palmer, and J.M. Steinbach-Rankins. Journal of Controlled Release, 2020. 321: p. 84-99. PMID[32035194]. PMCID[PMC7170769].
[PubMed]. HIV_04_2020.
19. Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-targeting Small Molecules. Vernekar, S.K.V., R.L. Sahani, M.C. Casey, J. Kankanala, L. Wang, K.A. Kirby, H. Du, H. Zhang, P.R. Tedbury, J. Xie, S.G. Sarafianos, and Z. Wang. Viruses, 2020. 12(4): E452. PMID[32316297].
[PubMed]. HIV_04_2020.
20. Platinum(II) and Ruthenium(II) Complexes in Medicine: Antimycobacterial and Anti-HIV Activities. Yufanyi, D.M., H.S. Abbo, S.J.J. Titinchi, and T. Neville. Coordination Chemistry Reviews, 2020. 414: 213285. ISI[000525870200003].
[WOS]. HIV_04_2020.
21. Natural-Product-Library-based Screening for Discovery of Capsid C-terminal Domain Targeted HIV-1 Inhibitors. Zhang, D.W., R.H. Luo, L. Xu, L.M. Yang, X.S. Xu, Y.T. Zheng, and H. Luo. International Journal of Antimicrobial Agents, 2020. 55(4): 105926. PMID[32092396].
[PubMed]. HIV_04_2020.
22. The Selenium-containing Drug Ebselen Potently Disrupts LEDGF/P75-HIV-1 Integrase Interaction by Targeting LEDGF/P75. Zhang, D.W., H.L. Yan, X.S. Xu, L. Xu, Z.H. Yin, S. Chang, and H. Luo. Journal of Enzyme Inhibition and Medicinal Chemistry, 2020. 35(1): p. 906-912. PMID[32228103]. PCMID [PMC7170385].
[PubMed]. HIV_04_2020.
Patent Citations
23. Novel Screening Assays for Identifying Compounds Modulating HIV-1 Latency by Modulating the Expression Level of the HIV-1 Vpu Gene or Protein in Relation to Binding to NF-kB.Altfeld, M. and G. Martrus Zapater. Patent. 2020. 2018-199748 3636781: 26pp.
[Patent]. HIV_04_2020.
24. Preparation of Indazolyl Pyrimidine Derivatives as Inhibitors of Human Immunodeficiency Virus Replication for the Treatment of HIV Infection. Iwuagwu, C. and K.M. Peese. Patent. 2020. 2019-IB57814 2020058844: 88pp.
[Patent]. HIV_04_2020.
25. Novel Pyrrole and Pyridone Derivatives as Antiviral Agents and Their Preparation. Jee, J.-A., N.R. Gade, and T.D. Roper. Patent. 2020. 2019-US44382 2020081143: 65pp.
[Patent]. HIV_04_2020.
26. Preparation of Pyrazoles as Inhibitors of HIV-1 Nef for the Treatment of HIV Disease. Smithgall, T., A. Reitz, J. Wrobel, C. Tice, T. Haimowitz, M. Carlsen, M. Loughran, and H. Ye. Patent. 2020. 2019-US56800 2020081856: 183pp.
[Patent]. HIV_04_2020.